Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Tr (Q71519298)
Jump to navigation
Jump to search
scientific article published on 01 November 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Tr |
scientific article published on 01 November 1995 |
Statements
Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG) (English)
de Witte T
Suciu S
Peetermans M
Strijckmans P
Hayat M
Jaksic B
Selleslag D
Zittoun R
1 November 1995